Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury

NCT03003364 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injury, Chronic

Interventions

DRUG: XCEL-UMC-BETA
DRUG: Placebo

Sponsor

Banc de Sang i Teixits

Collaborators

[object Object]
[object Object]
[object Object]